Batten Grafting for Nasal Valve Collapse
Trial Summary
What is the purpose of this trial?
This trial compares adding supportive pieces to standard nasal surgery with just the standard surgery alone. It targets patients with blocked noses due to a crooked septum. The added support helps keep the nose open and improves airflow.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Batten Grafting for Nasal Valve Collapse?
Research shows that various techniques for reducing the size of the inferior turbinates, such as submucosal resection and radiofrequency ablation, effectively improve nasal breathing by reducing nasal obstruction. These methods have been shown to improve symptoms significantly, as indicated by reduced Nasal Obstruction Symptom Evaluation (NOSE) scores, and have low complication rates.12345
Is Batten Grafting for Nasal Valve Collapse generally safe in humans?
Research on similar procedures like inferior turbinate reduction shows they are generally safe, with no significant complications reported in studies, especially in children. Techniques like microdebrider and coblation have been evaluated for safety and found to have minimal adverse side effects.16789
How does the Batten Grafting for Nasal Valve Collapse treatment differ from other treatments for nasal valve collapse?
This treatment is unique because it combines batten grafting, which supports the nasal structure, with inferior turbinate reduction and septoplasty to address both structural and airflow issues, potentially offering a more comprehensive solution for nasal valve collapse compared to treatments that focus solely on one aspect.1351011
Research Team
David Hiltzik, MD
Principal Investigator
Northwell Health
Eligibility Criteria
This trial is for adults over 18 with breathing obstruction due to a deviated septum, enlarged turbinates, and external nasal valve collapse. Candidates must be able to consent and have these conditions confirmed by clinical examination. It's not for those with septal perforation, untreated/unresponsive allergic rhinitis, past nose surgeries, or concurrent sinus/polyp surgery.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo septoplasty and turbinate reduction, with or without batten grafting
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of nasal obstruction and other outcomes
Treatment Details
Interventions
- Batten Graft (Procedure)
- Inferior Turbinate Reduction (Procedure)
- Septoplasty (Procedure)
Inferior Turbinate Reduction is already approved in Canada, Japan for the following indications:
- Nasal obstruction
- Chronic nasal congestion
- Enlarged inferior turbinates
- Nasal obstruction
- Chronic rhinitis
- Allergic rhinitis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwell Health
Lead Sponsor
Michael Dowling
Northwell Health
Chief Executive Officer since 2002
Bachelor's and Master's degrees from University College Cork, Ireland
Dr. David Battinelli
Northwell Health
Chief Medical Officer since 2022
MD from Georgetown University School of Medicine